News
The company completed a clinical trial at nine centers across the U.S., Europe and Asia before it received FDA approval.
New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...
Dr. Simrit Parmar, a Northwestern University-trained oncologist and research scientist, launched Cellenkos Inc., in 2016 to ...
3h
ZME Science on MSNResearchers stop Parkinson’s symptoms in mice using a copper supplement. Could humans be next?A team of neuroscientists in Australia has found that restoring copper levels in the brain dramatically reduced Parkinson-like damage in mice. The approach restored a protein’s function, and the same ...
A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...
The findings of two recent studies give hope that the disease could one day be reversed in humans—but experts warn that this ...
Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...
2don MSN
Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...
In its last fund raising round last year, Insightec’s valuation was at just $515 million, as emerges from the financials of listed company Elbit Medical, which holds 2% of Insightec.
2d
ZME Science on MSNA Common Cough Syrup Might Protect the Brain in Parkinson’s DementiaThe drug is Ambroxol. It’s been used for decades to treat respiratory ailments by thinning mucus and easing coughs. But now, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results